1. Home
  2. GSBC vs IOVA Comparison

GSBC vs IOVA Comparison

Compare GSBC & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

N/A

Current Price

$79.55

Market Cap

870.9M

Sector

Finance

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$10.05

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSBC
IOVA
Founded
1923
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.9M
1.7B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
GSBC
IOVA
Price
$79.55
$10.05
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$65.00
$9.00
AVG Volume (30 Days)
70.2K
13.0M
Earning Date
04-15-2026
05-07-2026
Dividend Yield
2.54%
N/A
EPS Growth
17.68
14.84
EPS
2.99
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
$2.56
$40.31
P/E Ratio
$26.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$53.76
$1.76
52 Week High
$82.91
$9.36

Technical Indicators

Market Signals
Indicator
GSBC
IOVA
Relative Strength Index (RSI) 54.43 70.70
Support Level $76.29 $3.82
Resistance Level $82.19 N/A
Average True Range (ATR) 1.42 0.42
MACD 0.11 -0.01
Stochastic Oscillator 70.26 86.11

Price Performance

Historical Comparison
GSBC
IOVA

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: